Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · IEX Real-Time Price · USD
0.470
-0.019 (-3.87%)
At close: Jul 19, 2024, 4:00 PM
0.475
+0.005 (1.06%)
Pre-market: Jul 22, 2024, 7:35 AM EDT
Enveric Biosciences Stock Forecast
ENVB's stock price has decreased by -83.79% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Enveric Biosciences stock has a target of 10, which predicts an increase of 2,027.66% from the current stock price of 0.47.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 30, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for ENVB is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +2,027.66% | Jan 30, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $63 | Strong Buy | Initiates | $63 | +13,197.87% | Jun 1, 2022 |
| Aegis Capital | Aegis Capital | Strong Buy → Hold Downgrades $350 → $10 | Strong Buy → Hold | Downgrades | $350 → $10 | +2,027.66% | Mar 8, 2022 |
| Aegis Capital | Aegis Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jul 8, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jun 28, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.96
from -8.09
EPS Next Year
-1.54
from -1.96
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 15.8M | 26.3M |
| Avg | n/a | n/a | n/a | 15.3M | 25.5M |
| Low | n/a | n/a | n/a | 14.7M | 24.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 71.6% |
| Avg | - | - | - | - | 66.7% |
| Low | - | - | - | - | 60.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.86 | -1.48 | -1.84 |
| Avg | -1.96 | -1.54 | -1.79 |
| Low | -2.04 | -1.57 | -1.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.